Oxford Endovascular

Oxford Endovascular is a healthcare company in Oxford, United Kingdom, founded in 2015. It has raised $10.0M across 2 rounds, most recently an Extension Round in May 2024.

oxfordendovascular

Headquarters
Oxford
Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$10.0M
Last Round
Extension RoundMay 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Oxford Endovascular is developing a next-generation flow-diverter for intracranial aneurysms that are at risk of rupture. The device is designed to redirect blood flow away from the aneurysm, addressing the condition through a change in blood flow. Its stated development focus is a novel flow-diversion device for these aneurysms.

Summary

It lists 1–10 employees. It has raised $10.0M in total across 2 rounds, most recently a Extension Round in May 2024. Investors include Parkwalk Advisors, Vulpes Investment Management and Oxford Science Enterprises.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries A+May 2024
GBP 8.0M

Sign up to see all 2 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Oxford Endovascular on Indexed.vc
<a href="https://indexed.vc/companies/oxford-endovascular"><img src="https://indexed.vc/api/badge/company/oxford-endovascular" alt="Oxford Endovascular on Indexed.vc" width="260" height="76" /></a>